Larimar Therapeutics Statistics
NASDAQ: LRMRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.14-0.08 (-2.48%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Larimar Therapeutics by the numbers
Larimar Therapeutics has a market capitalization of $328.6 million based on 104.63M shares outstanding. With trailing EPS of $-1.67, Larimar Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.0% above its 50-day average and 16.5% below its 200-day average.
Average daily trading volume is 1.38M shares, or about $4.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LRMR valuation vs. peer median
| Metric | LRMR | Peer median | Difference |
|---|---|---|---|
| Market cap | $328.55M | $335.47M | -2% |
| Avg. volume | 1.38M | 617.37K | +124% |
Peer median across 8 companies: INO, MPLT, AVIR, CTNM, PEPG, SPRY, ASPE, PBYI.
Valuation
- Market cap
- $328.55M
- EPS (TTM)
- $-1.67
- Shares outstanding
- 104.63M
Price and trading
- Previous close
- 3.22
- Open
- 3.15
- Day range
- 2.96 – 3.22
- 52-week range
- 1.92 – 6.42
- 52-week change
- -11.80%
- Beta
- —
- Volume
- 1.71M
- Average volume
- 1.38M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 16, 2026
Additional statistics
- Market Cap
- 328.55M
- Forward Pe
- -3.47
- Eps
- -1.67
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.42
- Week52 Low
- 1.92
- Avg Volume
- 1.38M
- Shares Outstanding
- 104.63M
- Ma50
- 2.85
- Ma200
- 3.76
- Earnings Date
- Nov 16, 2026
- Pct From52w High
- -51.09%
- Pct From52w Low
- 63.97%